Summary
CVS Health Corporation (CVS) filed an 8-K on January 26, 2016, to report significant amendments to its By-laws, approved by the Board of Directors on January 21, 2016. The most notable change is the introduction of a 'proxy access' provision, allowing a qualifying stockholder or a group of up to 20 stockholders, holding at least 3% of outstanding common stock for a minimum of three years, to nominate director candidates for inclusion in the company's proxy materials. This provision permits nominations of up to the greater of two individuals or 20% of the Board. These amendments also include various other updates, clarifications, and conforming changes to the By-laws. These adjustments address details such as the timing of annual stockholder meetings, procedures for adjourned meetings, conduct and voting standards at meetings, advance notice requirements to accommodate proxy access, the date for determining contested elections, and the roles of certain officers. Investors should note that these By-law changes represent a shift in corporate governance, potentially increasing stockholder influence in board nominations.
Key Highlights
- 1CVS Health adopted amendments to its By-laws on January 21, 2016.
- 2A key amendment introduces a 'proxy access' provision allowing certain stockholders to nominate directors.
- 3The proxy access provision requires a minimum 3% stock ownership for at least three years by a single stockholder or a group of up to 20.
- 4Eligible stockholders can nominate up to the greater of two directors or 20% of the Board.
- 5The By-laws were updated to reflect these changes, including advance notice provisions.
- 6Other amendments clarified meeting procedures, voting standards, and officer roles.
- 7The amendments are effective as of January 21, 2016.